Global Endocrine Testing Market - Forecasts From 2018 to 2023
The global endocrine testing market is projected to grow at a CAGR of 6.64%, increasing from US$8.215 billion in 2017 to US$12.080 billion in 2023. Endocrine testing refers to the measuring of endocrine hormone concentration for the diagnosis of various diseases such as diabetes, hyperthyroidism, infertility etc. Endocrine hormones are secreted by various endocrine glands directly into the bloodstream and regulates body functions such as metabolism, homeostasis, stimuli response etc. and any imbalance in these hormones may lead to the development of various disorders such as diabetes, growth disorders, hyperthyroidism and a host of other hormone-related disorders. Endocrine testing market is expected to show a robust growth during the given forecast period. Sedentary lifestyles leading to the development of the stress and other related disorders such as diabetes and obesity have given a boost to the market. Introduction of easy-to-operate test kits which are user-friendly and cost-effective will also drive the market for endocrine testing during the given time frame. However, high cost of development of the technology for endocrine testing might restrain the market growth for the given forecast period.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global endocrine testing market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global endocrine testing market.
Major industry players profiled as part of the report are Hoffmann-La Roche Ltd, Thermo Fisher Scientific, and Abbott among others.
Segmentation
By Technology
Liquid Chromatography-Mass Spectrometry (LC-MS)
Immunoassay
ELISA
Tandem Mass spectrometry
Others
By Application
Cortisol Test
Human Chorionic Gonadotropin (HCG) Test
Dehydroepiandrosterone Sulfate (DHEAS) Test
Thyroid Stimulating Hormone (TSH) Test
Prolactin Test
Insulin
Others
By End Users
Hospitals and Clinics
Diagnostic Centres
By Geography
North America
United States
Canada
Others
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
China
India
Australia
South Korea
Others
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global endocrine testing market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global endocrine testing market.
Major industry players profiled as part of the report are Hoffmann-La Roche Ltd, Thermo Fisher Scientific, and Abbott among others.
Segmentation
By Technology
Liquid Chromatography-Mass Spectrometry (LC-MS)
Immunoassay
ELISA
Tandem Mass spectrometry
Others
By Application
Cortisol Test
Human Chorionic Gonadotropin (HCG) Test
Dehydroepiandrosterone Sulfate (DHEAS) Test
Thyroid Stimulating Hormone (TSH) Test
Prolactin Test
Insulin
Others
By End Users
Hospitals and Clinics
Diagnostic Centres
By Geography
North America
United States
Canada
Others
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
China
India
Australia
South Korea
Others
1. INTRODUCTION
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. KEY FINDINGS OF THE STUDY
4. MARKET DYNAMICS
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. GLOBAL ENDOCRINE TESTING MARKET FORECAST BY TECHNOLOGY
5.1. Liquid Chromatography-Mass Spectrometry (LC-MS)
5.2. Immunoassay
5.3. ELISA
5.4. Tandem Mass spectrometry
5.5. Others
6. GLOBAL ENDOCRINE TESTING MARKET FORECAST BY APPLICATION
6.1. Cortisol Test
6.2. Human Chorionic Gonadotropin (HCG) Test
6.3. Dehydroepiandrosterone Sulfate (DHEAS) Test
6.4. Thyroid Stimulating Hormone (TSH) Test
6.5. Prolactin Test
6.6. Insulin
6.7. Others
7. GLOBAL ENDOCRINE TESTING MARKET FORECAST BY END USERS
7.1. Hospitals and Clinics
7.2. Diagnostic Centres
8. GLOBAL ENDOCRINE TESTING MARKET FORECAST BY GEOGRAPHY (US$ BILLION)
8.1. North America
8.1.1. The U.S
8.1.2. Canada
8.1.3. Mexico
8.1.4. Others
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. U.K.
8.3.2. France
8.3.3. Germany
8.3.4. Italy
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Saudi Arabia
8.4.2. UAE
8.4.3. Israel
8.4.4. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. India
8.5.3. Australia
8.5.4. South Korea
8.5.5. Others
9. COMPETITIVE INTELLIGENCE
9.1. Market Share Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals
10. COMPANY PROFILES
10.1. Randox Laboratories Ltd.
10.1.1. Overview
10.1.2. Financials
10.1.3. Product and Services
10.1.4. Recent Developments
10.2. Abbott
10.2.1. Overview
10.2.2. Financials
10.2.3. Product and Services
10.2.4. Recent Developments
10.3. Agilent Technologies
10.3.1. Overview
10.3.2. Financials
10.3.3. Product and Services
10.3.4. Recent Developments
10.4. bioMerieux SA
10.4.1. Overview
10.4.2. Financials
10.4.3. Product and Services
10.4.4. Recent Developments
10.5. Bio Rad Laboratories
10.5.1. Overview
10.5.2. Financials
10.5.3. Product and Services
10.5.4. Recent Developments
10.6. Hoffmann-La Roche Ltd
10.6.1. Overview
10.6.2. Financials
10.6.3. Product and Services
10.6.4. Recent Developments
10.7. Beckman Coulter, Inc.
10.7.1. Overview
10.7.2. Financials
10.7.3. Product and Services
10.7.4. Recent Developments
10.8. Siemens Healthineers
10.8.1. Overview
10.8.2. Financials
10.8.3. Product and Services
10.8.4. Recent Developments
10.9. Thermo Fisher Scientific
10.9.1. Overview
10.9.2. Financials
10.9.3. Product and Services
10.9.4. Recent Developments
10.10. AB Sciex
10.10.1. Overview
10.10.2. Financials
10.10.3. Product and Services
10.10.4. Recent Developments
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. KEY FINDINGS OF THE STUDY
4. MARKET DYNAMICS
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. GLOBAL ENDOCRINE TESTING MARKET FORECAST BY TECHNOLOGY
5.1. Liquid Chromatography-Mass Spectrometry (LC-MS)
5.2. Immunoassay
5.3. ELISA
5.4. Tandem Mass spectrometry
5.5. Others
6. GLOBAL ENDOCRINE TESTING MARKET FORECAST BY APPLICATION
6.1. Cortisol Test
6.2. Human Chorionic Gonadotropin (HCG) Test
6.3. Dehydroepiandrosterone Sulfate (DHEAS) Test
6.4. Thyroid Stimulating Hormone (TSH) Test
6.5. Prolactin Test
6.6. Insulin
6.7. Others
7. GLOBAL ENDOCRINE TESTING MARKET FORECAST BY END USERS
7.1. Hospitals and Clinics
7.2. Diagnostic Centres
8. GLOBAL ENDOCRINE TESTING MARKET FORECAST BY GEOGRAPHY (US$ BILLION)
8.1. North America
8.1.1. The U.S
8.1.2. Canada
8.1.3. Mexico
8.1.4. Others
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. U.K.
8.3.2. France
8.3.3. Germany
8.3.4. Italy
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Saudi Arabia
8.4.2. UAE
8.4.3. Israel
8.4.4. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. India
8.5.3. Australia
8.5.4. South Korea
8.5.5. Others
9. COMPETITIVE INTELLIGENCE
9.1. Market Share Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals
10. COMPANY PROFILES
10.1. Randox Laboratories Ltd.
10.1.1. Overview
10.1.2. Financials
10.1.3. Product and Services
10.1.4. Recent Developments
10.2. Abbott
10.2.1. Overview
10.2.2. Financials
10.2.3. Product and Services
10.2.4. Recent Developments
10.3. Agilent Technologies
10.3.1. Overview
10.3.2. Financials
10.3.3. Product and Services
10.3.4. Recent Developments
10.4. bioMerieux SA
10.4.1. Overview
10.4.2. Financials
10.4.3. Product and Services
10.4.4. Recent Developments
10.5. Bio Rad Laboratories
10.5.1. Overview
10.5.2. Financials
10.5.3. Product and Services
10.5.4. Recent Developments
10.6. Hoffmann-La Roche Ltd
10.6.1. Overview
10.6.2. Financials
10.6.3. Product and Services
10.6.4. Recent Developments
10.7. Beckman Coulter, Inc.
10.7.1. Overview
10.7.2. Financials
10.7.3. Product and Services
10.7.4. Recent Developments
10.8. Siemens Healthineers
10.8.1. Overview
10.8.2. Financials
10.8.3. Product and Services
10.8.4. Recent Developments
10.9. Thermo Fisher Scientific
10.9.1. Overview
10.9.2. Financials
10.9.3. Product and Services
10.9.4. Recent Developments
10.10. AB Sciex
10.10.1. Overview
10.10.2. Financials
10.10.3. Product and Services
10.10.4. Recent Developments
